Emerging roles of E2Fs in cancer: an exit from cell cycle control (original) (raw)
Attwooll, C., Lazzerini Denchi, E. & Helin, K. The E2F family: specific functions and overlapping interests. EMBO J.23, 4709–4716 (2004). ArticleCASPubMedPubMed Central Google Scholar
Trimarchi, J. M. & Lees, J. A. Sibling rivalry in the E2F family. Nature Rev. Mol. Cell Biol.3, 11–20 (2002). ArticleCAS Google Scholar
Harbour, J. W. & Dean, D. C. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev.14, 2393–2409 (2000). ArticleCASPubMed Google Scholar
Burkhart, D. L. & Sage, J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nature Rev. Cancer8, 671–682 (2008). ArticleCAS Google Scholar
DeGregori, J. & Johnson, D. G. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr. Mol. Med.6, 739–748 (2006). CASPubMed Google Scholar
Dimova, D. K. & Dyson, N. J. The E2F transcriptional network: old acquaintances with new faces. Oncogene24, 2810–2826 (2005). ArticleCASPubMed Google Scholar
Ren, B. et al. E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints. Genes Dev.16, 245–256 (2002). ArticleCASPubMedPubMed Central Google Scholar
Cam, H. et al. A common set of gene regulatory networks links metabolism and growth inhibition. Mol. Cell16, 399–411 (2004). ArticleCASPubMed Google Scholar
Dimova, D. K., Stevaux, O., Frolov, M. V. & Dyson, N. J. Cell cycle-dependent and cell cycle-independent control of transcription by the Drosophila E2F/RB pathway. Genes Dev.17, 2308–2320 (2003). By coupling RNA interference with gene expression arrays, this study shows that E2F family members can control the transcription of genes other than those associated with the cell cycle. ArticleCASPubMedPubMed Central Google Scholar
Wells, J., Graveel, C. R., Bartley, S. M., Madore, S. J. & Farnham, P. J. The identification of E2F1-specific target genes. Proc. Natl Acad. Sci. USA99, 3890–3895 (2002). ArticleCASPubMedPubMed Central Google Scholar
Takahashi, Y., Rayman, J. B. & Dynlacht, B. D. Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev.14, 804–816 (2000). CASPubMedPubMed Central Google Scholar
Wells, J., Boyd, K. E., Fry, C. J., Bartley, S. M. & Farnham, P. J. Target gene specificity of E2F and pocket protein family members in living cells. Mol. Cell. Biol.20, 5797–5807 (2000). ArticleCASPubMedPubMed Central Google Scholar
Jin, V. X., Rabinovich, A., Squazzo, S. L., Green, R. & Farnham, P. J. A computational genomics approach to identify _cis_-regulatory modules from chromatin immunoprecipitation microarray data — a case study using E2F1. Genome Res.16, 1585–1595 (2006). ArticleCASPubMedPubMed Central Google Scholar
Zalmas, L. P. et al. DNA-damage response control of E2F7 and E2F8. EMBO Rep.9, 252–259 (2008). ArticlePubMedCAS Google Scholar
Li, J. et al. Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development. Dev. Cell14, 62–75 (2008). ArticleCASPubMedPubMed Central Google Scholar
Buttitta, L. A. & Edgar, B. A. Mechanisms controlling cell cycle exit upon terminal differentiation. Curr. Opin. Cell Biol.19, 697–704 (2007). ArticleCASPubMedPubMed Central Google Scholar
Bieda, M., Xu, X., Singer, M. A., Green, R. & Farnham, P. J. Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome. Genome Res.16, 595–605 (2006). ArticleCASPubMedPubMed Central Google Scholar
McClellan, K. A. & Slack, R. S. Specific in vivo roles for E2Fs in differentiation and development. Cell Cycle6, 2917–2927 (2007). ArticleCASPubMed Google Scholar
Kovesdi, I., Reichel, R. & Nevins, J. R. Identification of a cellular transcription factor involved in E1A trans-activation. Cell45, 219–228 (1986). ArticleCASPubMed Google Scholar
Yee, A. S., Reichel, R., Kovesdi, I. & Nevins, J. R. Promoter interaction of the E1A-inducible factor E2F and its potential role in the formation of a multi-component complex. EMBO J.6, 2061–2068 (1987). References 22 and 23 describe the identification of E2F (from the nuclear extracts of adenovirus-infected cells) as the cellular factor responsible for binding and activating the adenovirus early E2 promoter, which drives viral DNA replication. ArticleCASPubMedPubMed Central Google Scholar
Helin, K. et al. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell70, 337–350 (1992). ArticleCASPubMed Google Scholar
Kaelin, W. G. et al. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell70, 351–364 (1992). ArticleCASPubMed Google Scholar
Johnson, D. G., Schwarz, J. K., Cress, W. D. & Nevins, J. R. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature365, 349–352 (1993). ArticleCASPubMed Google Scholar
Arias, E. E. & Walter, J. C. Strength in numbers: preventing rereplication via multiple mechanisms in eukaryotic cells. Genes Dev.21, 497–518 (2007). ArticleCASPubMed Google Scholar
Malumbres, M. & Barbacid, M. Mammalian cyclin-dependent kinases. Trends Biochem. Sci.30, 630–641 (2005). ArticleCASPubMed Google Scholar
Blain, S. W. Switching cyclin D-Cdk4 kinase activity on and off. Cell Cycle7, 892–898 (2008). ArticleCASPubMed Google Scholar
Tsai, S.-Y. et al. Mouse development with a single E2F activator. Nature454, 1137–1141 (2008). This study showsin vivothat the activators E2F1, E2F3a and E2F3b have interchangeable roles in the control of mammalian development and provides the first genetic and molecular evidence of their functional plasticity. ArticleCASPubMedPubMed Central Google Scholar
Danielian, P. S. et al. E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity. Oncogene27, 6561–6570 (2008). ArticleCASPubMedPubMed Central Google Scholar
Gaubatz, S. et al. E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. Mol. Cell6, 729–735 (2000). ArticleCASPubMed Google Scholar
Duronio, R. J., O'Farrell, P. H., Xie, J. E., Brook, A. & Dyson, N. The transcription factor E2F is required for S phase during Drosophila embryogenesis. Genes Dev.9, 1445–1455 (1995). ArticleCASPubMed Google Scholar
Frolov, M. V. et al. Functional antagonism between E2F family members. Genes Dev.15, 2146–2160 (2001). References 34 and 35 are classic studies inD. melanogasterthat have contributed to the understanding of fundamental principles of E2F-mediated cell cycle control. ArticleCASPubMedPubMed Central Google Scholar
Ambrus, A., Nicolay, B., Rasheva, V., Suckling, R. & Frolov, M. dE2F2-independent rescue of proliferation in cells lacking an activator dE2F1. Mol. Cell. Biol.27, 8561–8570 (2007). ArticleCASPubMedPubMed Central Google Scholar
Lammens, T., Li, J., Leone, G. & De Veylder, L. Atypical E2Fs: new players in the E2F transcription factor family. Trends Cell Biol.3, 111–118 (2009). ArticleCAS Google Scholar
Lammens, T. et al. Atypical E2F activity restrains APC/CCCS52A2 function obligatory for endocycle onset. Proc. Natl Acad. Sci. USA.105, 14721–14726 (2008). ArticleCASPubMedPubMed Central Google Scholar
Ramirez-Parra, E. et al. Role of an atypical E2F transcription factor in the control of Arabidopsis cell growth and differentiation. Plant Cell16, 2350–2363 (2004). ArticleCASPubMedPubMed Central Google Scholar
Christensen, J. et al. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription. Nucleic Acids Res.33, 5458–5470 (2005). ArticleCASPubMedPubMed Central Google Scholar
Di Stefano, L., Jensen, M. R. & Helin, K. E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes. EMBO J.22, 6289–6298 (2003). ArticleCASPubMedPubMed Central Google Scholar
Tsai, K. Y. et al. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol. Cell2, 293–304 (1998). ArticleCASPubMed Google Scholar
Ziebold, U., Reza, T., Caron, A. & Lees, J. A. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev.15, 386–391 (2001). ArticleCASPubMedPubMed Central Google Scholar
Lee, E. Y. et al. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature359, 288–294 (1992). ArticleCASPubMed Google Scholar
Clarke, A. R. et al. Requirement for a functional Rb-1 gene in murine development. Nature359, 328–330 (1992). ArticleCASPubMed Google Scholar
Chong, J.-L. et al. E2f3a and E2f3b contribute to the control of cell proliferation and mouse development. Mol. Cell. Biol.2, 414–424 (2009). ArticleCAS Google Scholar
Aslanian, A., Iaquinta, P. J., Verona, R. & Lees, J. A. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics. Genes Dev.12, 1413–1422 (2004). Article Google Scholar
Miki, J., Fujimura, Y., Koseki, H. & Kamijo, T. Polycomb complexes regulate cellular senescence by repression of ARF in cooperation with E2F3. Genes Cells12, 1371–1382 (2007). ArticleCASPubMed Google Scholar
Leone, G. et al. Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins. Mol. Cell. Biol.10, 3626–3632 (2000). Article Google Scholar
Xu, X. et al. A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members. Genome Res.17, 1550–1561 (2007). ArticleCASPubMedPubMed Central Google Scholar
Young, A. P., Nagarajan, R. & Longmore, G. D. Mechanisms of transcriptional regulation by Rb-E2F segregate by biological pathway. Oncogene22, 7209–7217 (2003). ArticleCASPubMed Google Scholar
Lim, C. A. et al. Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-κB upon TLR4 activation. Mol. Cell27, 622–635 (2007). ArticleCASPubMed Google Scholar
Leung, J. Y., Ehmann, G. L., Giangrande, P. H. & Nevins, J. R. A role for Myc in facilitating transcription activation by E2F1. Oncogene27, 4172–4179 (2008). ArticleCASPubMed Google Scholar
Timchenko, N. A., Wilde, M. & Darlington, G. J. C/EBPα regulates formation of S-phase-specific E2F–p107 complexes in livers of newborn mice. Mol. Cell. Biol.19, 2936–2945 (1999). ArticleCASPubMedPubMed Central Google Scholar
Iakova, P., Awad, S. S. & Timchenko, N. A. Aging reduces proliferative capacities of liver by switching pathways of C/EBPα growth arrest. Cell113, 495–506 (2003). ArticleCASPubMed Google Scholar
Malumbres, M. & Barbacid, M. Cell cycle, CDKs and cancer: a changing paradigm. Nature Rev. Cancer9, 153–166 (2009). ArticleCAS Google Scholar
Yu, Q. et al. Requirement for CDK4 kinase function in breast cancer. Cancer Cell9, 23–32 (2006). ArticleCASPubMed Google Scholar
Reddy, H. K. et al. Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis. Cancer Res.65, 10174–10178 (2005). ArticleCASPubMed Google Scholar
Williams, B. O. et al. Cooperative tumorigenic effects of germline mutations in Rb and p53. Nature Genet.7, 480–484 (1994). ArticleCASPubMed Google Scholar
Hu, N. et al. Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene9, 1021–1027 (1994). CASPubMed Google Scholar
Yamasaki, L. et al. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1+/− mice. Nature Genet.18, 360–364 (1998). ArticleCASPubMed Google Scholar
Opavsky, R. et al. CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells. PLoS Genet.3, 1757–1769 (2007). ArticleCASPubMed Google Scholar
Ziebold, U., Lee, E. Y., Bronson, R. T. & Lees, J. A. E2F3 loss has opposing effects on different pRB-deficient tumors, resulting in suppression of pituitary tumors but metastasis of medullary thyroid carcinomas. Mol. Cell. Biol.23, 6542–6552 (2003). ArticleCASPubMedPubMed Central Google Scholar
Maandag, E. C. et al. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J.13, 4260–4268 (1994). ArticleCASPubMedPubMed Central Google Scholar
Williams, B. O. et al. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J.13, 4251–4259 (1994). ArticleCASPubMedPubMed Central Google Scholar
Parisi, T. et al. Selective requirements for E2f3 in the development and tumorigenicity of Rb-deficient chimeric tissues. Mol. Cell. Biol.6, 2283–2293 (2007). ArticleCAS Google Scholar
Ceol, C. J. & Horvits, H. R. dpl-1 DP and efl-1 E2F act with lin-35 Rb to antagonize Ras signaling in C. elegans vulval development. Mol. Cell7, 461–473 (2001). ArticleCASPubMed Google Scholar
Myers, T. R. & Greenwald, I. lin-35 Rb acts in the major hypodermis to oppose ras-mediated vulval induction in C. elegans. Dev. Cell8, 117–123 (2005). References 70 and 71 represent just two in a series of elegant studies demonstrating a role for RB–E2F in the regulation of cell fate specification inC. elegans . ArticleCASPubMed Google Scholar
de Bruin, A. et al. Rb function in extraembryonic lineages suppresses apoptosis in the CNS of Rb-deficient mice. Proc. Natl Acad. Sci. USA100, 6546–6551 (2003). ArticleCASPubMedPubMed Central Google Scholar
Wu, L. et al. Extra-embryonic function of Rb is essential for embryonic development and viability. Nature421, 942–947 (2003). ArticleCASPubMed Google Scholar
Opavsky, R. et al. Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis. Proc. Natl Acad. Sci. USA104, 15400–15405 (2007). ArticleCASPubMedPubMed Central Google Scholar
Saenz-Robles, M. T. et al. Intestinal hyperplasia induced by simian virus 40 large tumor antigen requires E2F2. J. Virol.81, 13191–13199 (2007). ArticleCASPubMedPubMed Central Google Scholar
Lee, E. Y. et al. E2F4 loss suppresses tumorigenesis in Rb mutant mice. Cancer Cell2, 463–472 (2002). ArticleCASPubMed Google Scholar
Parisi, T. Bronson, R. T. & Lees, J. A. Inhibition of pituitary tumors in Rb mutant chimeras through E2f4 loss reveals a key suppressive role for the pRB/E2F pathway in urothelium and ganglionic carcinogenesis. Oncogene28, 500–508 (2009). ArticleCASPubMed Google Scholar
Infante, A. et al. E2F2 represses cell cycle regulators to maintain quiescence. Cell Cycle7, 3915–3927 (2008). ArticleCASPubMed Google Scholar
Pagano, M. & Jackson, P. K. Wagging the dogma; tissue-specific cell cycle control in the mouse embryo. Cell118, 535–538 (2004). ArticleCASPubMed Google Scholar
Sherr, C. J. & Roberts, J. M. Living with or without cyclins and cyclin-dependent kinases. Genes Dev.18, 2699–2711 (2004). ArticleCASPubMed Google Scholar
Santamaria, D. et al. Cdk1 is sufficient to drive the mammalian cell cycle. Nature448, 811–815 (2007). This landmark study shows that interphase CDKs — CDK2, CDK4 and CDK6 — are not essential for cell division in the mammal as their combined genetic ablation does not alter the cell cycle of most cell types. ArticleCASPubMed Google Scholar
Satyanarayana, A. et al. Genetic substitution of Cdk1 by Cdk2 leads to embryonic lethality and loss of meiotic function of Cdk2. Development135, 3389–3400 (2008). ArticleCASPubMed Google Scholar
Wu, L. et al. The E2F1–3 transcription factors are essential for cellular proliferation. Nature414, 457–462 (2001). ArticleCASPubMed Google Scholar
Yamasaki, L. et al. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell85, 537–548 (1996). ArticleCASPubMed Google Scholar
Field, S. J. et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell85, 549–561 (1996). Contrary to expectations, references 85 and 86 providein vivoevidence of a role for E2F1 in the suppression of cell proliferation and tumorigenesis. ArticleCASPubMed Google Scholar
Murga, M. et al. Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity15, 959–970 (2001). ArticleCASPubMed Google Scholar
Humbert, P. O. et al. E2F4 is essential for normal erythrocyte maturation and neonatal viability. Mol. Cell6, 281–291 (2000). ArticleCASPubMed Google Scholar
Rempel, R. E. et al. Loss of E2F4 activity leads to abnormal development of multiple cellular lineages. Mol. Cell6, 293–306 (2000). ArticleCASPubMed Google Scholar
Lindeman, G. J. et al. A specific, nonproliferative role for E2F-5 in choroid plexus function revealed by gene targeting. Genes Dev.12, 1092–1098 (1998). ArticleCASPubMedPubMed Central Google Scholar
Pohlers, M. et al. A role for E2F6 in the restriction of male-germ-cell-specific gene expression. Curr. Biol.15, 1051–1057 (2005). ArticleCASPubMed Google Scholar
Timmers, C. et al. E2f1, E2f2, and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback loop. Mol. Cell. Biol.27, 65–78 (2007). ArticleCASPubMedPubMed Central Google Scholar
Sharma, N. et al. Control of the p53-p21CIP1 axis by E2f1, E2f2, and E2f3 is essential for G1/S progression and cellular transformation. J. Biol. Chem.281, 36124–36131 (2006). ArticleCASPubMed Google Scholar
Midorikawa, Y., Makuuchi, M., Tang, W. & Aburatani, H. Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges. World J. Gastroenterol.13, 1487–1492 (2007). ArticleCASPubMedPubMed Central Google Scholar
Midorikawa, Y. et al. Distinct chromosomal bias of gene expression signatures in the progression of hepatocellular carcinoma. Cancer Res.64, 7263–7270 (2004). ArticleCASPubMed Google Scholar
Zondervan, P. E. et al. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias. J. Pathol.192, 207–215 (2000). ArticleCASPubMed Google Scholar
Wang, G. et al. Genetic aberration in primary hepatocellular carcinoma: correlation between p53 gene mutation and loss-of-heterozygosity on chromosome 16q21-q23 and 9p21-p23. Cell Res.10, 311–323 (2000). ArticleCASPubMed Google Scholar
Hovey, R. M. et al. Genetic alterations in primary bladder cancers and their metastases. Cancer Res.58, 3555–3560 (1998). CASPubMed Google Scholar
Yu, D. S., Hsieh, D. S. & Chang, S. Y. Detection of chromosomal alterations in bladder cancer by comparative genomic hybridization. BJU Int.87, 889–893 (2001). ArticleCASPubMed Google Scholar
Veltman, J. A. et al. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res.63, 2872–2880 (2003). CASPubMed Google Scholar
Feber, A. et al. Amplification and overexpression of E2F3 in human bladder cancer. Oncogene23, 1627–1630 (2004). ArticleCASPubMed Google Scholar
Hurst, C. D., Tomlinson, D. C., Williams, S. V., Platt, F. M. & Knowles, M. A. Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification. Oncogene27, 2716–2727 (2008). ArticleCASPubMed Google Scholar
Grasemann, C. et al. Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma. Oncogene24, 6441–6449 (2005). ArticleCASPubMed Google Scholar
Orlic, M., Spencer, C. E., Wang, L. & Gallie, B. L. Expression analysis of 6p22 genomic gain in retinoblastoma. Genes Chromosom. Cancer45, 72–82 (2006). References 103–106 report the curious observation that amplification and/or overexpression of E2F3 occurs in human tumours with RB inactivation. ArticleCASPubMed Google Scholar
Szymanska, J. et al. Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization. Genes Chromosom. Cancer15, 89–94 (1996). ArticleCASPubMed Google Scholar
Szymanska, J. et al. Overrepresentation of 1q21–23 and 12q13–21 in lipoma-like liposarcomas but not in benign lipomas: a comparative genomic hybridization study. Cancer Genet. Cytogenet.99, 14–18 (1997). ArticleCASPubMed Google Scholar
Alonso, M. M. et al. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. J. Natl Cancer Inst.97, 1589–1600 (2005). ArticleCASPubMed Google Scholar
Wikenheiser-Brokamp, K. A. Retinoblastoma regulatory pathway in lung cancer. Curr. Mol. Med.6, 783–793 (2006). CASPubMed Google Scholar
Imai, M. A., Oda, Y., Oda, M., Nakanishi, I. & Kawahara, E. Overexpression of E2F1 associated with LOH at RB locus and hyperphosphorylation of RB in non-small cell lung carcinoma. J. Cancer Res. Clin. Oncol.130, 320–326 (2004). ArticleCASPubMed Google Scholar
Eymin, B., Gazzeri, S., Brambilla, C. & Brambilla, E. Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma. Oncogene20, 1678–1687 (2001). ArticleCASPubMed Google Scholar
Cooper, C. S. et al. Nuclear overexpression of the E2F3 transcription factor in human lung cancer. Lung Cancer54, 155–162 (2006). ArticlePubMed Google Scholar
Reimer, D. et al. Expression of the E2F family of transcription factors and its clinical relevance in ovarian cancer. Ann. NY Acad. Sci.1091, 270–281 (2006). ArticleCASPubMed Google Scholar
Reimer, D. et al. Clinical relevance of E2F family members in ovarian cancer — an evaluation in a training set of 77 patients. Clin. Cancer Res.13, 144–151 (2007). ArticleCASPubMed Google Scholar
Han, S. et al. E2F1 expression is related with the poor survival of lymph node-positive breast cancer patients treated with fluorouracil, doxorubicin and cyclophosphamide. Breast Cancer Res. Treat.82, 11–16 (2003). ArticleCASPubMed Google Scholar
Rakha, E. A., Pinder, S. E., Paish, E. C., Robertson, J. F. & Ellis, I. O. Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis. J. Pathol.203, 754–761 (2004). ArticleCASPubMed Google Scholar
Gauthier, M. L. et al. Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors. Cancer Cell12, 479–491 (2007). ArticleCASPubMedPubMed Central Google Scholar
Lee, J. et al. Impact of E2F-1 expression on clinical outcome of gastric adenocarcinoma patients with adjuvant chemoradiation therapy. Clin. Cancer Res.14, 82–88 (2008). ArticleCASPubMed Google Scholar
Bramis, J. et al. E2F-1 transcription factor immunoexpression is inversely associated with tumor growth in colon adenocarcinomas. Anticancer Res.24, 3041–3047 (2004). CASPubMed Google Scholar
Haller, F. et al. Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors. Clin. Cancer Res.11, 6589–6597 (2005). ArticleCASPubMed Google Scholar
Janoueix-Lerosey, I. et al. Gene expression profiling of 1p35–36 genes in neuroblastoma. Oncogene23, 5912–5922 (2004). ArticleCASPubMed Google Scholar
Furukawa, T., Sunamura, M. & Horii, A. Molecular mechanisms of pancreatic carcinogenesis. Cancer Sci.97, 1–7 (2006). ArticleCASPubMed Google Scholar
Rigaud, G. et al. Allelotype of pancreatic acinar cell carcinoma. Int. J. Cancer88, 772–777 (2000). ArticleCASPubMed Google Scholar
Bindra, R. S. & Glazer, P. M. Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia. Oncogene26, 2048–2057 (2007). ArticleCASPubMed Google Scholar
Bindra, R. S. & Glazer, P. M. Basal repression of BRCA1 by multiple E2Fs and pocket proteins at adjacent E2F sites. Cancer Biol. Ther.5, 1400–1407 (2006). ArticleCASPubMed Google Scholar
Polanowska, J. et al. Human E2F5 gene is oncogenic in primary rodent cells and is amplified in human breast tumors. Genes Chromosom. Cancer28, 126–130 (2000). ArticleCASPubMed Google Scholar
Umemura, S. et al. Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome. Br. J. Cancer100, 764–771 (2009). ArticleCASPubMedPubMed Central Google Scholar
Reimer, D. et al. Expression of the E2F family of transcription factors and its clinical relevance in ovarian cancer. Ann. NY Acad. Sci.1091, 270–281 (2006). ArticleCASPubMed Google Scholar
Reimer, D. et al. Clinical relevance of E2F family members in ovarian cancer – an evaluation in a training set of 77 patients. Clin. Cancer Res.13, 144–151 (2007). ArticleCASPubMed Google Scholar
Endo-Munoz, L. et al. E2F7 can regulate proliferation, differentiation, and apoptotic responses in human keratinocytes: implications for cutaneous squamous cell carcinoma formation. Cancer Res.69, 1800–1808 (2009). ArticleCASPubMed Google Scholar
Chen, D., Gallie, B. L. & Squire, J. A. Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization. Cancer Genet. Cytogenet.129, 57–63 (2001). ArticleCASPubMed Google Scholar
Lindblad-Toh, K. et al. Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays. Nature Biotechnol.18, 1001–1005 (2000). ArticleCAS Google Scholar
Karakaidos, P. et al. Overexpression of the replication licensing regulators hCdt1 and hCdc6 characterizes a subset of non-small-cell lung carcinomas: synergistic effect with mutant p53 on tumor growth and chromosomal instability — evidence of E2F-1 transcriptional control over hCdt1. Am. J. Pathol.165, 1351–1365 (2004). ArticleCASPubMedPubMed Central Google Scholar
Qin, G. et al. Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF. Proc. Natl Acad. Sci. USA103, 11015–11020 (2006). ArticleCASPubMedPubMed Central Google Scholar
Muller, H. et al. Induction of S-phase entry of E2F transcription factors depends on their nuclear localization. Mol. Cell. Biol.17, 5508–5520 (1997). ArticleCASPubMedPubMed Central Google Scholar
Yarden, Y. & Sliwkowski, M. X. Untangling the ErbB signaling network. Nature Rev. Mol. Cell Biol.2, 127–137 (2001). ArticleCAS Google Scholar
Hynes, N. E. & Lane, H. A. ERBB receptors and cancer: the complexity of targeted inhibitors. Nature Rev. Cancer5, 341–354 (2005). ArticleCAS Google Scholar
Harbour, J. W. et al. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell98, 859–869 (1999). ArticleCASPubMed Google Scholar
Malumbres, M. & Barbacid, M. To cycle or not to cycle: a critical decision in cancer. Nature Rev. Cancer1, 222–231 (2001). ArticleCAS Google Scholar
Magae, J. et al. Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members. J. Cell Sci.109, 1717–1726 (1996). CASPubMed Google Scholar
Verona, R. et al. E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol. Cell. Biol.17, 7268–7282 (1997). ArticleCASPubMedPubMed Central Google Scholar
Gaubatz, S., Lees, J. A., Lindeman, G. J. & Livingston, D. M. E2F4 is exported from the nucleus in a CRM1-dependent manner. Mol. Cell. Biol.21, 1384–1392 (2001). ArticleCASPubMedPubMed Central Google Scholar
Cartwright, P. et al. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene17, 611–623 (1998). ArticleCASPubMed Google Scholar
Gaubatz, S., Wood, J. G. & Livingston, D. M. Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6. Proc. Natl Acad. Sci. USA95, 9190–9195 (1998). ArticleCASPubMedPubMed Central Google Scholar
Trimarchi, J. M., Farichild, B., Wen, J. & Lees, J. A. The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. Proc. Natl Acad. Sci. USA98, 1519–1524 (2001). ArticleCASPubMedPubMed Central Google Scholar
Leone, G. et al. E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev.12, 2120–2130 (1998). This paper and reference 87 show that E2F3 has a central role in the control of cell proliferationin vitroby mediating activation of most of the classic E2F target genes in response to mitogenic stimulation. ArticleCASPubMedPubMed Central Google Scholar
Tyagi, S., Chabes, A. L., Wysocka, J. & Herr, W. E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. Mol. Cell27, 107–119 (2007). ArticleCASPubMed Google Scholar
Ogawa, H., Ishiguro, K., Gaubatz, S., Livingston, D. M. & Nakatani, Y. A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. Science296, 1132–1136 (2002). ArticleCASPubMed Google Scholar
Rayman, J. B. et al. E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev.16, 933–947 (2002). ArticleCASPubMedPubMed Central Google Scholar
Brehm, A. et al. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature391, 597–601 (1998). ArticleCASPubMed Google Scholar
Taubert, S. et al. E2F-dependent histone acetylation and recruitment of the Tip60 acetyltransferase complex to chromatin in late G1. Mol. Cell. Biol.24, 4546–4556 (2004). ArticleCASPubMedPubMed Central Google Scholar
Nicolas, E., Roumillac, C. & Trouche, D. Balance between acetylation and methylation of histone H3 lysine 9 on the E2F-responsive dihydrofolate reductase promoter. Mol. Cell. Biol.23, 1614–1622 (2003). ArticleCASPubMedPubMed Central Google Scholar
Lang, S. E., McMahon, S. B., Cole, M. D. & Hearing, P. E2F transcriptional activation requires TRRAP and GCN5 cofactors. J. Biol. Chem.276, 32627–32634 (2001). ArticleCASPubMed Google Scholar
Li, F. X. et al. The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss. Proc. Natl Acad. Sci. USA100, 12935–12940 (2003). ArticleCASPubMedPubMed Central Google Scholar
Iglesias, A. et al. Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice. J. Clin. Invest.113, 1398–1407 (2004). ArticleCASPubMedPubMed Central Google Scholar
Kinross, K. M., Clark, A. J., Iazzolino, R. M. & Humbert, P. O. E2f4 regulates fetal erythropoiesis through the promotion of cellular proliferation. Blood108, 886–895 (2006). ArticleCASPubMed Google Scholar
Olson, M. V. et al. Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors. Cancer Res.67, 4005–4009 (2007). ArticleCASPubMed Google Scholar
Conner, E. A. et al. Dual functions of E2F-1 in transgenic mouse model of liver carcinogenesis. Oncogene19, 5054–5062 (2000). ArticleCASPubMed Google Scholar
Chen, Q., Hung, F. C., Fromm, L. & Overbeek, P. A. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2. Invest. Ophthalmol. Vis. Sci.41, 4223–4231 (2000). CASPubMed Google Scholar
Guy, C. T., Zhou, W., Kaufman, S. & Robinson, M. O. E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes. Mol. Cell. Biol.16, 685–693 (1996). ArticleCASPubMedPubMed Central Google Scholar
Holmberg, C., Helin, K., Sehested, M. & Karlstrom, O. E2F-1-induced p53-independent apoptosis in transgenic mice. Oncogene17, 143–155 (1998). ArticleCASPubMed Google Scholar
Pierce, A. M., Fisher, S. M., Conti, C. J. & Johnson, D. G. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development. Oncogene16, 1267–1276 (1998). ArticleCASPubMed Google Scholar
Pierce, A. M. et al. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model. Mol. Cell. Biol.19, 6408–6414 (1999). ArticleCASPubMedPubMed Central Google Scholar
Scheijen, B., Bronk, M., van der Meer, T., De Jong, D. & Bernards, R. High incidence of thymic epithelial tumors in E2F2 transgenic mice. J. Biol. Chem.279, 10476–10483 (2004). ArticleCASPubMed Google Scholar
Paulson, Q. X., McArthur, M. J. & Johnson, D. G. E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model. Cell Cycle5, 184–190 (2006). ArticleCASPubMed Google Scholar
Chen, Q., Liang, D. Yang, T., Leone, G. & Overbeek, P. A. Distinct capacities of individual E2Fs to induce cell cycle re-entry in postmitotic lens fiber cells of transgenic mice. Dev. Neurosci.26, 435–445 (2004). ArticleCASPubMed Google Scholar
Wang, D., Russell, J. L. & Johnson, D. G. E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo. Mol. Cell. Biol.20, 3417–3424 (2000). ArticleCASPubMedPubMed Central Google Scholar
Chen, Q., Liang, D. & Overbeek, P. A. Overexpression of E2F5/p130, not E2F5 alone, can inhibit E2F-induced cell cycle entry in transgenic mice. Mol. Vis.25, 602–614 (2008). CAS Google Scholar
Fujita, Y. et al. Chromosome arm 20q gains and other genomic alterations in esophageal squamous cell carcinoma, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Hepatogastroenterology50, 1857–1863 (2003). CASPubMed Google Scholar
Wilting, S. M. et al. Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer. Genes Chromosom. Cancer47, 890–905 (2008). ArticleCASPubMed Google Scholar
Wilting, S. M. et al. Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. J. Pathol.209, 220–230 (2006). ArticleCASPubMed Google Scholar
Huang, C. L. et al. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer. Clin. Cancer Res.13, 6938–6946 (2007). ArticleCASPubMed Google Scholar
Gorgoulis, V. G. et al. Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas. J. Pathol.198, 142–156 (2002). ArticleCASPubMed Google Scholar
Mega, S. et al. Cyclin D1, E2F1 expression levels are associated with characteristics and prognosis of esophageal squamous cell carcinoma. Dis. Esophagus18, 109–113 (2005). ArticleCASPubMed Google Scholar
Ebihara, Y. et al. Over-expression of E2F-1 in esophageal squamous cell carcinoma correlates with tumor progression. Dis. Esophagus17, 150–154 (2004). ArticleCASPubMed Google Scholar
Xu, X. R. et al. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc. Natl Acad. Sci. USA98, 15089–15094 (2001). ArticleCASPubMedPubMed Central Google Scholar
Llovet, J. M. & Bruix, J. Molecular targeted therapies in hepatocellular carcinoma. Hepatology48, 1312–1327 (2008). ArticleCASPubMed Google Scholar
Yamazaki, K. et al. Expression of transcription factor E2F-1 in pancreatic ductal carcinoma: an immunohistochemical study. Pathol. Res. Pract.199, 23–28 (2003). ArticlePubMed Google Scholar
Haller, F. et al. Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors. Clin. Cancer Res.11, 6589–6597 (2005). ArticleCASPubMed Google Scholar
Han, S. et al. E2F1 expression is related with the poor survival of lymph node-positive breast cancer patients treated with fluorouracil, doxorubicin and cyclophosphamide. Breast Cancer Res. Treat82, 11–16 (2003). ArticleCASPubMed Google Scholar
De Meyer, T. et al. E2Fs mediate a fundamental cell-cycle deregulation in high-grade serous ovarian carcinomas. J. Pathol.217, 14–20 (2009). ArticleCASPubMed Google Scholar
Lee, J. et al. Impact of E2F-1 expression on clinical outcome of gastric adenocarcinoma patients with adjuvant chemoradiation therapy. Clin. Cancer Res.14, 82–88 (2008). ArticleCASPubMed Google Scholar
Kwong, R. A. et al. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue. Clin. Cancer Res.9, 3705–3711 (2003). CASPubMed Google Scholar
Bramis, J. et al. E2F-1 transcription factor immunoexpression is inversely associated with tumor growth in colon adenocarcinomas. Anticancer Res.24, 3041–3047 (2004). CASPubMed Google Scholar
Rabbani, F. et al. Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization. J. Natl Cancer Inst.91, 874–881 (1999). ArticleCASPubMed Google Scholar
Ried, T. et al. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res.54, 1801–1806 (1994). CASPubMed Google Scholar
Weber-Hall, S. et al. Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization. Cancer Res.56, 3220–3224 (1996). CASPubMed Google Scholar
Tarkkanen, M. et al. DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma. Intl J. Cancer84, 114–121 (1999). ArticleCAS Google Scholar
Janoueix-Lerosey, I. et al. Gene expression profiling of 1p35–36 genes in neuroblastoma. Oncogene23, 5912–5922 (2004). ArticleCASPubMed Google Scholar
Aarts, M. et al. Microarray-based CGH of sporadic and syndrome-related pheochromocytomas using a 0.1–02 Mb bacterial artificial chromosome array spanning chromosome arm 1p. Genes Chromosom. Cancer45, 83–93 (2006). ArticleCASPubMed Google Scholar
Bieche, I., Khodja, A. & Lidereau, R. Deletion mapping of chromosomal region 1p32-pter in primary breast cancer. Genes Chromosom. Cancer24, 255–263 (1999). ArticleCASPubMed Google Scholar
Speicher, M. R. et al. Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization. Cancer Res.54, 3817–3823 (1994). CASPubMed Google Scholar
Kallioniemi, A. et al. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc. Natl Acad. Sci. USA91, 2156–2160 (1994). ArticleCASPubMedPubMed Central Google Scholar
Nishizaki, T. et al. Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosom. Cancer19, 267–272 (1997). ArticleCASPubMed Google Scholar
Foster, C. S. et al. Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome. Oncogene23, 5871–5879 (2004). ArticleCASPubMed Google Scholar
Sakai, K., Nagahara, H., Abe, K. & Obata, H. Loss of heterozygosity on chromosome 16 in hepatocellular carcinoma. J. Gastroenterol. Hepatol.7, 288–292 (1992). ArticleCASPubMed Google Scholar
Cleton-Jansen, A. M. et al. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions. Cancer Res.61, 1171–1177 (2001). CASPubMed Google Scholar
Rakha, E. A., Armour, J. A., Pinder, S. E., Paish, C. E. & Ellis, I. O. High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry. Int. J. Cancer114, 720–729 (2005). ArticleCASPubMed Google Scholar
Mady, H. H., Hasso, S. & Melhem, M. F. Expression of E2F-4 gene in colorectal adenocarcinoma and corresponding covering mucosa: an immunohistochemistry, image analysis, and immunoblot study. Appl. Immunohistochem. Mol. Morphol.10, 225–230 (2002). ArticleCASPubMed Google Scholar
Ogata, S. et al. Microsatellite alterations and target gene mutations in the early stages of multiple gastric cancer. J. Pathol.194, 334–340 (2001). ArticleCASPubMed Google Scholar
Schwemmle, S. & Pfeifer, G. P. Genomic structure and mutation screening of the E2F4 gene in human tumors. Int. J. Cancer86, 672–677 (2000). ArticleCASPubMed Google Scholar
Souza, R. F. et al. Frequent mutation of the E2F-4 cell cycle gene in primary human gastrointestinal tumors. Cancer Res.57, 2350–2353 (1997). CASPubMed Google Scholar
Lassmann, S. et al. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas. J. Mol. Med.85, 293–304 (2007). ArticleCASPubMed Google Scholar
Fix, A. et al. Characterization of amplicons in neuroblastoma: High-resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genes. Genes Chromosom. Cancer47, 819–834 (2008). ArticleCASPubMed Google Scholar
Toraman, A. D., Keser, I., Luleci, G., Tunali, N. & Gelen, T. Comparative genomic hybridization in ganglioneuroblastomas. Cancer Genet. Cytogenet.132, 36–40 (2002). ArticleCASPubMed Google Scholar
Yin, X. L. et al. Analysis of loss of heterozygosity on chromosomes 10q, 11, and 16 in medulloblastomas. J. Neurosurg.94, 799–805 (2001). ArticleCASPubMed Google Scholar
Chen, D. et al. Division and apoptosis of E2f-deficient retinal progenitors. Nature (in the press).
Chong, J-L. et al. A switch of E2F1-3 function from activators in progenitor cells to repressors in differentiating cells. Nature (in the press).